Jun Yamamura
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Management of Malignant Psoas Syndrome From Breast Cancer: A Case Report.
Journal: Cureus
Published: May 19, 2025
Providing Opportunities for Close Examination of Lynch Syndrome after Microsatellite Instability Testing in a Hospital Setting
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 30, 2023
Administration Period of Olanzapine as an Antiemetic Drug for Patients on FEC Therapy-A Survey
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 08, 2022
Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive, HER2-negative breast cancer.
Journal: Breast disease
Published: August 23, 2021
Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.
Journal: Japanese journal of clinical oncology
Published: March 12, 2019
Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report.
Journal: Case reports in dermatology
Published: November 29, 2018
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study.
Journal: In vivo (Athens, Greece)
Published: October 15, 2018
The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer.
Journal: In vivo (Athens, Greece)
Published: November 27, 2017
Last Updated: 09/26/2026